Helmut Vorbrueggen

This inventor holds 43 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Kyowa Hakko Kogyo Co., Ltd.. Active years: 1978-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helmut Vorbrueggen. Retrieved from https://idiyas.com/inventor/helmut-vorbrueggen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 247(Granted Patents)

Company Filing History:

42 out of 1,409

Schering Aktiengesellschaft

patents

1 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

Years Active: 1978-2001

Loading Chart...

Areas of Expertise:

Prostaglandin Derivatives

Carbacyclins

Pharmaceutical Agents

Medicinal Use

Optical Resolution

Thromboxane

Cyclodextrin Clathrates

5-Cyano-Prostacyclins

Azaprostacyclins

Blood-Pressure-Lowering

Novel Compounds

Preparation Processes

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6225347 - 9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents (2001-05-01),

2. 5891910 - 9-halogen-(Z) prostaglandin derivatives, process for their production (1999-04-06),

3. 5523321 - Prostacyclins, their analogs or prostaglandins and thromboxane (1996-06-04),

4. 5204371 - Pharmaceutically active 9-chloroprostaglandins (1993-04-20),

5. 5190973 - 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals (1993-03-02),

6. 5162353 - Carbacyclins, processes for their preparation, and their use as (1992-11-10),

7. 5157042 - 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal (1992-10-20),

8. 5124343 - Carbacyclins, process for the preparation thereof, and use thereof as (1992-06-23),

9. 5093490 - Process for optical resolution of bicyclo[3.3.0]octane-3,7-dione-2 (1992-03-03),

10. 5079259 - Pharmaceutically active 9-chloroprostaglandins (1992-01-07),

11. 5013758 - Novel carbacyclins, processes for their preparation and their use as (1991-05-07),

12. 5010065 - Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use (1991-04-23),

13. 5004752 - Novel 9-haloprostaglandins, processes for their preparation, and their (1991-04-02),

14. 4971987 - New carbacycline, process for their production and their use as a drug (1990-11-20),

15. 4960907 - Process for the production of (1990-10-02),

Title: Helmut Vorbrueggen: A Prolific Innovator in Pharmaceutical Patents

Introduction

Helmut Vorbrueggen is a distinguished inventor based in Berlin, Germany. With an impressive portfolio of 43 patents, he has significantly contributed to the field of pharmaceuticals, particularly in the development of novel prostaglandin derivatives.

Latest Patents

Among his latest inventions are the 9-halogen-(Z)-prostaglandin derivatives. These unique compounds are described as 9-halogen-(Z) prostane derivatives represented by a specific formula. These innovations include a detailed process for their production and their use as pharmaceutical agents, highlighting their potential in medical applications.

Career Highlights

Vorbrueggen's career spans several notable organizations. He has worked with Schering Aktiengesellschaft, a renowned pharmaceutical company, and Kyowa Hakko Kogyo Co., Ltd., which is recognized for its contributions to biotechnology. His work in these companies has cemented his reputation as a leader in pharmaceutical research and innovation.

Collaborations

Throughout his career, Vorbrueggen has collaborated with esteemed colleagues, including Werner Skuballa and Bernd Raduechel. These partnerships have enabled him to leverage diverse expertise, further enhancing the impact of his inventions.

Conclusion

Helmut Vorbrueggen's innovative spirit and dedication to pharmaceutical research are evident through his numerous patents and collaborative efforts. His work continues to influence the field, paving the way for future advancements in pharmaceutical applications.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]